The Recall Desk
HighFDA (Devices)·Z-1626-2024·Announced 2024-05-01

Hip implant acetabular shell deburring defect triggers manufacturer recall

The TRIDENTII HEMI CLUSTER58F hip implant acetabular shell may have excessive deburring creating a smooth edge. Howmedica Osteonics Corp. is recalling affected units.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: FDA Class II medical device recall involving a manufacturing defect on an orthopedic implant used in high-risk patients. No injuries have been reported, placing this at High (3) per the rubric criterion of 'risk-of-harm products where injury has not yet been reported.'

Plain-English summary

Howmedica Osteonics Corp. is recalling the TRIDENTII HEMI CLUSTER58F hip implant due to a manufacturing defect in the acetabular shell component. Some affected units may have excessive deburring on the shell edge, resulting in a smooth surface.

The recalled implant is indicated for use in primary and revision patients at high risk of hip dislocation. Affected lots have been distributed nationwide and internationally to the Netherlands, Canada, Singapore, Spain, Sweden, and the United Kingdom.

Patients with questions about their implant should contact their healthcare provider or the manufacturer for guidance.

The recalled product

Product
TRIDENTII HEMI CLUSTER58F- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 702-11-58F
Manufacturer
Howmedica Osteonics Corp.
Hazard
  • deburring-defect
  • manufacturing-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI-DI: (01)07613327380958(17)290313(10) Lot Number: 15854353

Distribution

Distributed nationwide across the United States.